Bill Sponsor
House Bill 4400
116th Congress(2019-2020)
Advancing Education on Biosimilars Act of 2019
Introduced
Introduced
Introduced in House on Sep 19, 2019
Overview
Text
Introduced
Sep 19, 2019
Latest Action
Sep 20, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4400
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Indiana
Democrat
New York
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Advancing Education on Biosimilars Act of 2019

This bill requires the Department of Health and Human Services (HHS) to maintain a website and undertake other activities to educate health care providers, patients, and caregivers about biological products, biosimilar biological products, and interchangeable biosimilar biological products.

Among other activities, HHS must develop or improve continuing education programs that address clinical considerations for biological and related products. Health care providers eligible for the Merit-based Incentive Payment System in Medicare may count completion of such a program as a clinical practice improvement activity.

Text (1)
September 19, 2019
Actions (4)
09/20/2019
Referred to the Subcommittee on Health.
09/19/2019
Referred to the Subcommittee on Health.
09/19/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
09/19/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:56 PM